Medinova, Hyderabad: serology, endocrinology, ultrasound investigations magnetic resonance, imaging systems, colour dopplers, ECG Machines, cardiac stress system, Andhra Pradesh, indiamedical diagnostics, radiology, imageology, cardiology, gastroscopy, bio-Chemistry, haematology, micro-biology, histopathology, serology, endocrinology, ultrasound investigations magnetic resonance, imaging systems, colour dopplers, ECG Machines, cardiac stress system, Andhra Pradesh, india

Financials Investor Info Corporate Governance Stock Info Feedback

Annual Reports Quarterly Reports

Select Year:

Year 2016-17

Shareholding BDM Notice AGM Notice Media Advt Contact Registrar & Transfer Agents Handling & Redressal E-Voting

Select Year:

4th Quarter

Notice is hereby given that a meeting of Board of Directors is called and scheduled to be held on Tuesday, the 22nd May, 2018, at 11.30 a.m., at registered office of the company situated at H.No.7-1-58/A/FF/8, Office Flat/Unit No.8 Amrutha Business Complex, Ameerpet Hyderabad, Telangana-500016, India inter alia to consider and approve the audited financial results (both standalone and consolidated) for the 4th quarter and financial year ended 31st March, 2018, and balance sheet and profit and loss account as on that date.

We would also like to intimate that in view of the above stated board meeting, the trading window will remain closed from 15th May, 2018 to 25th May, 2018 (both days inclusive) for all directors/officers/ designated officials/ promoters and their immediate relatives.

3rd Quarter

Notice is hereby given that a meeting of Board of Directors is called and scheduled to be held on Wednesday, the 14th February, 2018 at 11.30 a.m. at the registered office of the company situated at Flat No. 206, 2nd Floor, MGR Estate, 6-3-456/C, Dwarakapuri Colony, Punjagutta, Hyderabad - 500082, Telangana, inter alia to consider and approve the un-audited financial results (both standalone and consolidated) for the third quarter ended 31st December, 2017 and also to consider the other items listed in draft Agenda

Further the notice is also given that in view of the above stated board meeting and as per the Company’s Code of Conduct on Insider Trading, the trading window will remain closed from 7th February, 2018 2017 to 16th February, 2018 (both days inclusive) for all directors/officers/designated officials/ promoters and their immediate relatives.

2nd Quarter

This is to inform you that a board of directors meeting is called and scheduled to be held on Monday, the 13th November, 2017 at 11.30 a.m. at the registered office of the company situated at Flat No. 206, 2nd Floor, MGR Estate, 6-3-456/C, Dwarakapuri Colony, Punjagutta, Hyderabad - 500082, Telangana, inter alia to consider and approve the un-audited financial results (both standalone and consolidated) for the second quarter and half year ended 30th September, 2017 and also to consider the other items listed in attached draft Agenda.

Further the notice is also given that in view of the above stated board meeting, as per the Company’s Code of Conduct on Insider Trading, the trading window will remain closed from 6th November, 2017 to 15th November, 2017 (both days inclusive) for all directors/officers/designated officials/ promoters and their immediate relatives

1st Quarter

Notice is hereby given that a meeting of Board of Directors is called and scheduled to be held on Monday, the 14thAugust, 2017 at 11.30 a.m. at the registered office of the company situated at Flat No. 206, 2nd Floor, MGR Estate, 6-3-456/C, Dwarakapuri Colony, Punjagutta, Hyderabad - 500082, Telangana, inter alia to consider and approve the un-audited financial results (both standalone and consolidated) for the first quarter ended 30th June, 2017 and also to consider the other items listed in Agenda

Further the notice is also given that in view of the above stated board meeting, as per the Company’s Code of Conduct on Insider Trading, the trading window will remain closed from 7thAugust, 2017 to 17th August, 2017 (both days inclusive) for all directors/officers/designated officials/ promoters and their immediate relatives.

24th AGM Notice

Contact Information & Address of the designated Official :-

Select Year:

Sri. N. Ravi Kumar,
Chief Financial Officer,
Medinova Diagnostic Services Limited,
6-3-456/C, 206 MGR Estates,
Hyderabad – 500 082.
Ph: 040-23310066
Email: medicorp@medinovaindia.com

Select Year:

M/s. XL Softech Systems Limited
#3, Sagar Society,
Road No.2 Banjara Hills,
HYDERABAD – 500 034
Ph: 040-23545913 / 14 / 15, Fax: 040-23553214

Select Year:

M/s. XL Softech Systems Limited
#3, Sagar Society,
Road No.2 Banjara Hills,
HYDERABAD – 500 034
Ph: 040-23545913 / 14 / 15, Fax: 040-23553214

Postal Ballot Results - September, 2017

POSTAL BALLOT :

Notice - November, 2016

Results - January, 2017

Voting results of 23rd AGM - 2016.

e-Voting and Physical Ballot Results Report by Scrutinizer – 2015

AGM Report as per Clause 35A of the Listing Agreement.

Board Directors Company Philosophy Policy Documents Compliance Report

Dr. Sura Surendranath Reddy – Chairman / Non-Executive Director:

Dr. Sura Surendranath Reddy (DIN 0108599 ) aged 66 years did his M.D. (Radiology) from Osmania Medical College, Hyderabad. He is a Medical Doctor by profession and is a founder Chairman of M/s. Vijaya Diagnostic Centre Private Limited (VDCPL). Dr. S Surendranath Reddy has established Diagnostic Centre as the centre of excellence for diagnostic Medicare, offering the most state of the art technologies and ensuring reliable and accurate services, in a professionally managed environment. He has vast experience in providing comprehensive range of diagnostic services spanning Radiology & Imaging, Nuclear Medicine, Conventional & Speciality Lab Services and Diagnostic Cardiology.Over the past 29 years, his passion for quality and commitment to delivering the latest in technology to customers, have translated into a number of First initiatives in Diagnostic Services by him. VDCPL today has over 33 branches and caters to over 6000 patients every day.

Mr. Sunil Chandra Kondapally – Managing Director:

Mr. Sunil Chandra Kondapally (DIN 01409332) is a B.Sc (Electrical Engineering) from Florida State University, USA. He is also Director of M/s. Vijaya Diagnostic Centre Private Limited and M/s. QPS Bioserve Clinical Services Private Limited. He has vast experience in medical field. Engineer by Qualification he has been closely involved in the operations, strategy administration at Vijaya Diagnostic Centre (Pvt.) Limited since 1998.Also founded a well recognized Contract researchpharmaceuticals company in 2004, which became a joint venture with QPS LLC, USA in 2011.

Mrs. Suprita Sura Reddy – Non-Executive Director:

Mrs. Suprita Sura Reddy (DIN 01206491) aged 33 years is a Master in Business Administration. She is a Executive Director and Chief Executive Officer of VijayaDiagnostic Centre Private Limited which is a pioneer in Diagnostic Medicare. She has vast experience in medical field. She has been closely involved in day to day operations and purchases of capex, inventory etc. in Vijaya Diagnostic Centre Private Limited.

Mr. K V Ravindra Reddy - Non-Executive Director:

Mr. K V Ravindra Reddy (DIN 00083986) aged 72 years is an expert in Corporate Legal affairs. He retired as Chief General Manager (Legal) in Andhra Pradesh Industrial Development Corporation and has rich experience in Corporate Business, Administration and Management.

Mr. P. Kamalakar Rao - Non-Executive Director:

Mr. P. Kamalakar Rao (DIN 03057676) aged 62 years is a senior fellow member of The Institute of Chartered Accountants of India. He is the managing partner of AMALAKARA RAO & CO. His other interests include sports, script writing for television serials, movies and documentaries. He has also produced television serials and movies in Hindi and English. His movie in English won many international awards.

Dr. G. Ramesh Ramayya - Non-Executive Director:

Dr. G. Ramesh Ramayya (DIN 00015424) aged 60 years is renowned Urologist. He did FRCS at Royal College of Surgeons, London and Edinburg. He also did his Master in Surgery (Urology) at University of Liverpool. He is the Chairman and CEO of Ramayya Pramila Healthcare Pvt. Limited. He has vast experience in Medical and Surgical Treatments for Prostate and related Urinary Problems. He won several awards and accolades for his contribution in the Medical and Surgical field.

The Company believes in fair business and Corporate Practices while dealing with all the shareholders, customers and others. The Company believes in discharging its statutory obligations and duties to its best ability.

Code of Conduct & Ethics :-